240 related articles for article (PubMed ID: 18262663)
41. [Changes in lipid metabolism with the use of alcohol deterrent preparations].
Selevich MI; Lelevich VV
Eksp Klin Farmakol; 1999; 62(1):70-4. PubMed ID: 10198774
[TBL] [Abstract][Full Text] [Related]
42. [Neurobiological aspects of alcoholism].
Anokhina IP
Vestn Akad Med Nauk SSSR; 1988; (3):21-7. PubMed ID: 3388967
[No Abstract] [Full Text] [Related]
43. Treating addiction, seriously.
Standridge JB
South Med J; 2008 Feb; 101(2):122. PubMed ID: 18364607
[No Abstract] [Full Text] [Related]
44. Gene-environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1.
Clarke TK; Schumann G
Pharmacol Biochem Behav; 2009 Sep; 93(3):230-6. PubMed ID: 19409922
[TBL] [Abstract][Full Text] [Related]
45. [The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence].
Łukasik K; Piątkowska K; Pietrzak B
Postepy Hig Med Dosw (Online); 2010 Oct; 64():534-43. PubMed ID: 21109706
[TBL] [Abstract][Full Text] [Related]
46. [Approaches to drug therapy of alcoholism].
Burov IuV
Vestn Akad Med Nauk SSSR; 1982; (5):72-7. PubMed ID: 7048788
[No Abstract] [Full Text] [Related]
47. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.
Heidbreder CA; Newman AH
Ann N Y Acad Sci; 2010 Feb; 1187():4-34. PubMed ID: 20201845
[TBL] [Abstract][Full Text] [Related]
48. Anticraving medication for moderate to severe alcohol use disorder.
Mong J; Ahamad K; Bach P
CMAJ; 2021 May; 193(19):E695. PubMed ID: 33972223
[No Abstract] [Full Text] [Related]
49. Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study.
Anton RF
Addiction; 2013 Oct; 108(10):1745-6. PubMed ID: 24033779
[No Abstract] [Full Text] [Related]
50. Medications acting on the dopaminergic system in the treatment of alcoholic patients.
Swift R
Curr Pharm Des; 2010; 16(19):2136-40. PubMed ID: 20482513
[TBL] [Abstract][Full Text] [Related]
51. [Pharmacological therapy of dependency on alcohol].
Alho H; Hyytiä P
Duodecim; 2009; 125(8):912-8. PubMed ID: 19492707
[TBL] [Abstract][Full Text] [Related]
52. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats.
Kemppainen H; Hyytiä P; Kiianmaa K
Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573
[TBL] [Abstract][Full Text] [Related]
53. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.
Leggio L; Cardone S; Ferrulli A; Kenna GA; Diana M; Swift RM; Addolorato G
Curr Pharm Des; 2010; 16(19):2159-18. PubMed ID: 20482506
[TBL] [Abstract][Full Text] [Related]
54. Consensus conference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment. Amsterdam, The Netherlands, September 16-17, 1994.
Alcohol Alcohol; 1996 Mar; 31 Suppl 1():1-87. PubMed ID: 8924128
[No Abstract] [Full Text] [Related]
55. Focus on: Neuroscience and treatment: the potential of neuroscience to inform treatment.
Koob GF
Alcohol Res Health; 2010; 33(1-2):144-51. PubMed ID: 23579944
[TBL] [Abstract][Full Text] [Related]
56. [Alcoholism: old and new approaches to diagnosis and therapy].
Meyer T
Praxis (Bern 1994); 1999 Feb; 88(8):328-32. PubMed ID: 10097642
[TBL] [Abstract][Full Text] [Related]
57. Recent animal models of alcoholism.
Spanagel R
Alcohol Res Health; 2000; 24(2):124-31. PubMed ID: 11199279
[TBL] [Abstract][Full Text] [Related]
58. Treatment of alcohol dependence with drug antagonists of the stress response.
Higley AE; Koob GF; Mason BJ
Alcohol Res; 2012; 34(4):516-21. PubMed ID: 23584117
[TBL] [Abstract][Full Text] [Related]
59. New drug treatments for alcohol problems. Response to Moncrieff & Drummond.
Lingford-Hughes A; Marshall J
Addiction; 1998 Jun; 93(6):925-7. PubMed ID: 9766928
[No Abstract] [Full Text] [Related]
60. [Is the concept of psychological dependence still valid today?].
Pinto E
Rev Med Liege; 2013; 68(5-6):262-71. PubMed ID: 23888575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
